We found that higher expression of IL13Rα2 and INHBA could individually predict worse DMFS of breast cancer patients with grade 3 but not with grade 1 or grade 2 tumors, while this was not observed for SMTN, VEGFA or GDF15 genes (Supplementary Figure S1). This evidence concerns the gene INHBA and breast carcinoma.